跳至主要内容
临床试验/CTRI/2026/03/106389
CTRI/2026/03/106389尚未招募2/3 期

Evaluation of Add on Effect of Vidangadi Churna Along with Metformin in Prameha with Reference to Type II Diabetes Mellitus Randomized Controlled Trial

VEDANT PANDURANG SHEJUL1 个研究点 分布在 1 个国家目标入组 76 人开始时间: 2026年4月1日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
76
试验地点
1

研究概览

简要总结

Prameha described in Ayurveda closely resembles Type-II Diabetes Mellitus, a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin resistance and impaired insulin secretion. Metformin is a widely used first-line drug for the management of Type-II Diabetes Mellitus; however, many patients require additional therapy for better glycemic control. Vidangadi Churna, an Ayurvedic polyherbal formulation mentioned in classical texts for the management of Prameha, possesses properties that may help in regulating metabolism and reducing blood glucose levels.

The present study is designed to evaluate the add-on effect of Vidangadi Churna along with Metformin in patients with Prameha with reference to Type-II Diabetes Mellitus. Participants will be randomly allocated into two groups: a control group receiving Metformin alone and a trial group receiving Metformin along with Vidangadi Churna for a specified treatment duration. The study aims to assess improvement in clinical symptoms and glycemic parameters to determine the efficacy of the combined therapy.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
35.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Diagnosed patient of type II DM having signs and symptoms of Prameha.
  • Patient having their Fasting blood glucose level range of 120-200 mg/dl.
  • Post prandial blood glucose level range of 180-250 mg/dl.
  • Patient having HbA1c up to 6-8
  • Urine Sugar++.

排除标准

  • K/C/O Pancreatic disorder.
  • Pregnant and lactating women.
  • Insulin-Dependent Diabetes Mellitus.
  • Patients with acute complications like K/C/O Hyperglycemic coma, K/C/O ketoacidosis and infections like K/C/O gangrene.
  • Patients with K/C/O Nephropathy, K/C/O Neuropathy .
  • History of alcohol abuse.

研究者

发起方
VEDANT PANDURANG SHEJUL
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

VEDANT PANDURANG SHEJUL

PMTS AYURVED COLLEGE SHEVGAON

研究点 (1)

Loading locations...

相似试验